Sharekhan

Suraksha Diagnostic Ltd

Fri 25/04/2025,15:53:10 | NSE : SURAKSHA

₹ 313.101.55 (0.50%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 311.55

Previous Close

₹ 311.55

Volume

99774

Mkt Cap ( Rs. Cr)

₹1630.65

High

₹ 314.45

Low

₹ 302.90

52 Week High

₹ 449.00

52 Week Low

₹ 231.00

Book Value Per Share

₹ 38.25

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Suraksha Diagnostic Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

313.10

434

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

434

Option Chain

Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Suraksha Diagnostic - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    10 Apr 2025, 12:42PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Suraksha Diagnostic - General Updates

    9 Apr 2025, 8:45PM Suraksha Diagnostic Limited has informed the Exchange about an Update on the Acquisition
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    9 Apr 2025, 8:37PM Intimation regarding update on acquisition under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    9 Apr 2025, 6:20PM As of March 2025, 48.78% is owned by Indian Promoters and 51.22% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    9 Apr 2025, 12:40PM Dr. Somnath Chatterjee has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    9 Apr 2025, 12:19PM Suraksha Diagnostic Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (S
  • Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2025, 12:53PM Suraksha Diagnostic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 12:46PM Compliance Certificate received from KFin Technologies Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of SEBI (Depo
  • Suraksha Diagnostic - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    8 Apr 2025, 12:37PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Suraksha Diagnostic - General Updates

    7 Apr 2025, 9:20PM Suraksha Diagnostic Limited has informed the Exchange about an Update on the Acquisition
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Mar 2025, 4:35PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of Analysts/ Institutional Investors/ Organizations meet to be held on 03 April 2
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Mar 2025, 4:29PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you of the schedule of the An
  • Suraksha Diagnostic - Acquisition-XBRL

    27 Mar 2025, 10:25PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange regarding Acquisition
  • Suraksha Diagnostic - General Updates

    27 Mar 2025, 10:20PM Suraksha Diagnostic Limited has informed the Exchange about acquisition
  • Suraksha Diagnostic - Outcome of Board Meeting

    27 Mar 2025, 10:11PM Suraksha Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2025.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Acquisition

    27 Mar 2025, 7:29PM Information about acquisition
  • Suraksha Diagnostic - Board Meeting Outcome for Outcome Of The Board Meeting Held On 27 March 2025

    27 Mar 2025, 7:26PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with the applicable SEBI
  • Suraksha Diagnostic - Trading Window-XBRL

    24 Mar 2025, 5:01PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange about Closure of Trading Window
  • Suraksha Diagnostic - Trading Window

    24 Mar 2025, 4:48PM Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Suraksha Diagnostic appoints Ravindra K. S as Group CFO

    7 Mar 2025, 4:49PM Suraksha Diagnostic Limited, the largest integrated diagnostic chain in East India, has announced the appointment of Mr. Ravindra K. S as Group Chief
  • Suraksha Diagnostic - Press Release

    7 Mar 2025, 4:18PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release in respect of appointment of Chief Financial Officer ( CFO ) "".
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    7 Mar 2025, 4:10PM Press release in respect of appointment of Chief Financial Officer (CFO) of the Company
  • Suraksha Diagnostic - Resignation

    17 Feb 2025, 4:46PM Suraksha Diagnostic Limited has informed the Exchange regarding Resignation of Mr as Chief Financial Officer of the company w.e.f. February 15, 2025.
  • Suraksha Diagnostic - General Updates

    17 Feb 2025, 4:40PM Suraksha Diagnostic Limited has informed the Exchange about the General Updates on the Resignation of Mr. Amit Saraf, Chief Financial Officer on 15 F
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    17 Feb 2025, 4:34PM In continuation of our letter dated 16 January 2025, we wish to inform you that Mr. Amit Saraf, Chief Financial Officer of the Company has resigned fr
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Feb 2025, 3:37PM Suraksha Diagnostic Limited has informed the Exchange about Transcript
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    14 Feb 2025, 3:13PM Please find the attached Transcript of the earning calls held on Monday 10, February, 2025.
  • Suraksha Diagnostic - Shareholders meeting

    10 Feb 2025, 6:11PM Suraksha Diagnostic Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Feb 2025, 3:05PM Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
  • Suraksha Diagnostic - Copy of Newspaper Publication

    10 Feb 2025, 1:26PM Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
  • Suraksha Diagnostic - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    10 Feb 2025, 5:58PM Voting Result of Postal Ballot along with the Scrutinizer's Report
  • Suraksha Diagnostic - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    10 Feb 2025, 5:54PM Intimation of the voting result of postal ballot.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    10 Feb 2025, 2:58PM Audio recording on the Analyst(s) / Investor(s) Meet/ Conference- 'Earnings Call' held on Monday, 10 February, 2025
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management

    8 Feb 2025, 7:32PM Appointment of Mr. Ravindra K S as the Chief Financial Officer with effect from 1st March, 2025, who will also act as a Group Chief Financial Officer
  • Suraksha Diagnostic - Appointment

    8 Feb 2025, 7:27PM Suraksha Diagnostic Limited has informed the Exchange regarding Appointment of Ravindra K S as Chief Financial Officer of the company w.e.f. March 01
  • Suraksha Diagnostic - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    8 Feb 2025, 7:15PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    8 Feb 2025, 7:04PM Press Release for the unaudited financial results (standalone and consolidated) for the quarter and nine months ended 31st December, 2024
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation

    8 Feb 2025, 6:56PM Investor Presentation on the unaudited financial results (standalone & consolidated) of the Company for the quarter and nine months 31st December, 202
  • Suraksha Diagnostic - Financial Result Updates

    8 Feb 2025, 6:48PM Suraksha Diagnostic Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Suraksha Diagnostic - Integrated Filing (Financial)

    8 Feb 2025, 6:47PM Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2024
  • Suraksha Diagnostic - Investor Presentation

    8 Feb 2025, 6:40PM Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation
  • Suraksha Diagnostic - Outcome of Board Meeting

    8 Feb 2025, 6:36PM Suraksha Diagnostic Limited has informed the Exchange regarding Board meeting held on February 08, 2025.
  • Suraksha Diagnostic - Integrated Filing- Financial

    8 Feb 2025, 6:22PM Integrated Filing (Financials) for the quarter and nine months ended 31 December 2024
  • Suraksha Diagnostic Q3 net profit up 29.01% at Rs 6.36 cr

    8 Feb 2025, 6:21PM The company reported standalone net profit of Rs 6.36 crore for the quarter ended December 31, 2024 as compared to Rs 4.93 crore in the same period la
  • Suraksha Diagnostic - Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Nine Months En

    8 Feb 2025, 6:20PM Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine months ended 31st December, 2024
  • Suraksha Diagnostic - Press Release

    8 Feb 2025, 6:18PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 08, 2025, titled ""Suraksha-Press Release-Q3 9M FY25"".
  • Suraksha Diagnostic - Outcome of Board Meeting

    8 Feb 2025, 6:14PM Suraksha Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on February 08, 2025.
  • Suraksha Diagnostic - Board Meeting Outcome for Outcome Of Board Meeting Held On 08 February 2025

    8 Feb 2025, 5:58PM 1. The unaudited financial results (standalone and consolidated) of the Company for the quarter and\r\nnine months ended 31 December 2024 and the same
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Feb 2025, 2:40PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    5 Feb 2025, 2:36PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,\r\nwe wish to inform you of the schedule of the
  • Suraksha Diagnostic - Board Meeting Intimation

    4 Feb 2025, 9:46AM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange about Board Meeting to be held on 08-Feb-2025 to inter-alia consider and approve the Unaudited F
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Feb 2025, 5:34PM Suraksha Diagnostic Limited has informed the Exchange about the Schedule of the meeting on Monday 10 February, 2025 at 11:00 am
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Feb 2025, 5:25PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conf
  • Suraksha Diagnostic - Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of

    3 Feb 2025, 11:46AM Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 ,inter alia, to consider

Key fundamentals

Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock 

Name March-24 March-23 March-22
Assets 189.5015 170.6301 169.0335
Liabilities 189.5015 170.6301 169.0335
Equity 6.9 6.9 6.9
Gross Profit 71.1917 44.9867 47.5072
Net Profit 24.3839 7.189 23.751
Cash From Operating Activities 61.23 44.9253 42.3306
NPM(%) 11.15 3.78 10.64
Revenue 218.5247 189.9854 223.1925
Expenses 147.333 144.9987 175.6853
ROE(%) 12.24 3.6 11.92

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 845.30 -3.65 11.93 177.49 1321.50 1.36
Lotus Eye Hospital and Institute Ltd 74.17 8.63 309.04 646.76 14.01 0.67
Vaishali Pharma Ltd 13.72 -4.32 457.33 333.37 2.76 0.00
Astec Lifesciences Ltd 709.65 -3.97 0.00 609.84 -687.11 0.00

Company Info

Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town

Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town

Read More

Parent Organisation

Suraksha Diagnostic Ltd.

Founded

15/03/2005

Managing Director

Ms.Ritu Mittal

NSE Symbol

SURAKSHAEQ

FAQ

The current price of Suraksha Diagnostic Ltd is ₹ 313.10.

The 52-week high for Suraksha Diagnostic Ltd is ₹ 314.45 and the 52-week low is ₹ 302.90.

The market capitalization of Suraksha Diagnostic Ltd is currently ₹ 1630.65. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Suraksha Diagnostic Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Suraksha Diagnostic Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Suraksha Diagnostic Ltd shares.

The CEO of Suraksha Diagnostic Ltd is Ms.Ritu Mittal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT